Last reviewed · How we verify
NCT05415189
Lifetime Incidence and Socio-economic Implications of Mental Illness
trial testing Not relevant in Mental Illness in 1,500,000 participants. Completed in 7 June 2022.
7 June 2022
Quick facts
| Lead sponsor | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,500,000 |
| Start date | 7 June 2022 |
| Primary completion | 7 June 2022 |
| Estimated completion | 7 June 2022 |
| Sites | 1 location across Denmark |
Drugs / interventions tested
- Not relevant
Conditions studied
- Mental Illness — all drugs for Mental Illness →
Sponsor
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
Who can join
Adults 1 to 110, any sex, with Mental Illness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the present study is to estimate the lifetime incidence of any mental disorder in a nationwide population-based register linkage study for the Danish population and to estimate the influence on socio-economic functioning.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Lifetime Incidence of Treated Mental Health Disorders and Psychotropic Drug Prescriptions and Associated Socioeconomic Functioning.
Kessing LV, Ziersen SC, Caspi A, Moffitt TE, et al · · 2023 · cited 27× · PMID 37436730 · DOI 10.1001/jamapsychiatry.2023.2206
Verify or expand the search:
- PubMed search for NCT05415189
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Not relevant
Trials testing the same drug.
- NCT02264470 — Fall Study in Gothenburg (FallsGOT) · completed
Other recruiting trials for Mental Illness
Currently open trials in the same condition.
- NCT07396623 — Validation of French PHQ-4 and PC-PTSD-5 Screening Scales · recruiting
- NCT05776316 — Harm Reduction Services · NA · recruiting
- NCT04881084 — Exploring Empathy and Compassion Using Digital Narratives · NA · recruiting
- NCT06290648 — Forging New Paths: Building Interventions to Treat Criminogenic Needs in Community Based Mental Health Settings · NA · active not recruiting
- NCT06315114 — A Transdiagnostic Mentalization-based Intervention for Parents With Mental Disorders · NA · recruiting
Other Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital trials
Trials by the same sponsor.
- NCT07404085 — Epigenetic Enhancement of Cognitive Training in Aging Mood Disorder Populations · NA · recruiting
- NCT07302165 — PreParent: Internet-based Digital Tools to Screen for and Prevent Postpartum Depression in Parents-to-be · NA · enrolling by invitation
- NCT06919133 — The Effect of Digital Markers in the Self-management of Depressive Symptoms · NA · enrolling by invitation
- NCT06755710 — Patient Engagement in PTSD Treatment (PEP) · NA · recruiting
- NCT06993831 — ENGAGE: Virtual Reality-based Psychotherapy for Negative Symptoms in Schizophrenia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05415189 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital
- Last refreshed: 14 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05415189.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing